Smallpox Research Grid Project Update This spring we launched the Smallpox Research Grid Project to analyze approximately 35 million molecules against a series of protein targets related to smallpox. This Project was made possible through the support of several Partner Organizations including: Accelrys, Evotec OAI, IBM, Oxford University, and numerous scientific researchers led by Dr. Grant McFadden and Dr. Stewart Shuman.
In the drug screening process used by this Project, when a molecule docks successfully with a protein it registers as a hit and is scored or ranked for strength of interaction. By binding to the particular site a successful drug candidate would disable the virus. The resulting data produced by the Project will consist of a list of "hits" and their relative scores. This ranked list of hits will then be further processed to help combat the use of smallpox as a bioterrorist threat.
Thanks to your efforts, we are more than halfway done with this project! American Diabetes Association Taps Power of Gateway Grid To Expedite Services To More Than 17 Million People We Recently announced that the ADA will use Gateway Processing On Demand?(GPOD), backed by United Device's Grid MP Alliance? platform, to accelerate critical diabetes-related research. The platform will run software to help the ADA analyze clinical programs and treatments, develop clinical practice guidelines, study the efficiency of care processes, set priorities and plan diabetes research. Previously, this required calculations that stretched the limits of normal computing resources and caused unacceptable delays. Read More!